Divalproex Sodium
NDC Package 50090-5843-0

11-digit billing NDC: 50090584300 · Billing unit: EA · 33 EA per package

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Divalproex Sodium is delayed-release tablets should not be administered to patients with hepatic disease or significant hepatic dysfunction [see Warnings and Precautions (5.1)]. Marketed by A-s Medication Solutions, this product is identified by NDC 50090-5843 and is authorized under FDA application ANDA090554.

Identification & Billing

NDC Package Code
50090-5843-0
Package Description
33 BLISTER PACK in 1 BOX, UNIT-DOSE / 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK
Product Code
11-Digit Billing Format
50090584300
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
33 EA
RxNorm Crosswalk
RxCUI: 1099870 - divalproex sodium 500 MG Delayed Release Oral Tablet

Clinical Specifications

Proprietary Name
Divalproex Sodium
Dosage Form
-
Usage Information
Divalproex sodium delayed-release tablets should not be administered to patients with hepatic disease or significant hepatic dysfunction [see Warnings and Precautions (5.1)]. Divalproex sodium delayed-release tablets are  contraindicated in patients known to have mitochondrial disorders caused by mutations in mitochondrial DNA polymerase γ (POLG; e.g., Alpers-Huttenlocher Syndrome) and children under two years of age who are suspected of having a POLG-related disorder [see Warnings and Precautions (5.1)]. Divalproex sodium delayed-release tablets are contraindicated in patients with known hypersensitivity to the drug [see Warnings and Precautions (5.12)].Divalproex sodium delayed-release tablets are contraindicated in patients with known urea cycle disorders [see Warnings and Precautions (5.6)].For use in prophylaxis of migraine headaches: Divalproex sodium delayed-release tablets are contraindicated in women who are pregnant and in women of childbearing potential who are not using effective contraception [see Warnings and Precautions (5.2, 5.3, 5.4) and Use in Specific Populations (8.1)].

Regulatory & Marketing

Labeler Name
A-s Medication Solutions
FDA Application #
ANDA090554
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
10-24-2014
Listing Expiration
12-31-2022
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50090-5843-0 identifies a specific commercial package of 33 blister pack in 1 box, unit-dose / 1 tablet, delayed release in 1 blister pack of Divalproex Sodium, labeled by A-s Medication Solutions. This product is billed for "EA" each discreet unit and contains an estimated amount of 33 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by A-s Medication Solutions on October 24, 2014. The current certification is valid through December 31, 2022.

How is this A-s Medication Solutions product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50090584300. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 33 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
50090-5843-0
11-Digit CMS (5-4-2)
50090-5843-00

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.